Handelen Utah Medical Products, Inc. - UTMD CFD
Toevoegen aan favorieten- Samenvatting
- Historische gegevens
- Evenementen
- Winst- en verliesrekening
- Balans
- Cash Flow
- Eigendom
Handelsvoorwaarden
| Spread | 1.73 | ||||||||
|
Overnight-tarief longpositie
Long position overnight fee
Ga naar platform | -0.025457% | ||||||||
|
Overnight-tarief shortpositie
Short position overnight fee
Ga naar platform | 0.003235% | ||||||||
| Tijd van overnight-tarief | 21:00 (UTC) | ||||||||
| Min. verhandelde hoeveelheid | 1 | ||||||||
| Valuta | USD | ||||||||
| Marge | 20% | ||||||||
| Effectenbeurs | United States of America | ||||||||
| Handelscommissie | 0% |
*Information provided by Capital.com
Utah Medical Products Inc ESG Risk Ratings
High Medium Low Negligible
‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.
Belangrijkste statistieken
| Prev. Close* | 93.48 |
| Open* | 91.93 |
| 1-Jaarlijkse Verandering* | 8.73% |
| Dagelijks bereik* | 91.93 - 94.94 |
| 52 wekelijks bereik | 80.10-109.50 |
| Weekgemiddelde volume (10 dagen) | 6,290.00 |
| Gemiddeld volume (3 maanden) | 175.93K |
| Marktkapitalisatie | 340.75M |
| P/E Ratio | 19.91 |
| Uitstaande Aandelen | 3.63M |
| Omzet | 52.48M |
| EPS | 4.72 |
| Dividend (opbrengst %) | 1.25639 |
| Beta | 0.20 |
| Volgende inkomsten datum | Jul 24, 2023 |
Alle gegevens zijn afkomstig van Refinitiv, behalve de gegevens gemarkeerd met een sterretje, die zijn afkomstig van Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Slotkoers | Change | Change (%) | Openingskoers | High | Low |
|---|---|---|---|---|---|---|
| Jun 2, 2023 | 94.03 | 2.09 | 2.27% | 91.94 | 94.98 | 91.93 |
| Jun 1, 2023 | 93.48 | 1.47 | 1.60% | 92.01 | 94.75 | 91.93 |
| May 31, 2023 | 92.74 | 2.26 | 2.50% | 90.48 | 93.65 | 88.44 |
| May 30, 2023 | 91.59 | -1.44 | -1.55% | 93.03 | 94.26 | 90.95 |
| May 26, 2023 | 94.93 | 1.91 | 2.05% | 93.02 | 94.93 | 91.93 |
| May 25, 2023 | 92.94 | -1.13 | -1.20% | 94.07 | 94.07 | 91.93 |
| May 24, 2023 | 92.51 | 0.58 | 0.63% | 91.93 | 93.63 | 91.93 |
| May 23, 2023 | 91.93 | 0.00 | 0.00% | 91.93 | 92.65 | 91.93 |
| May 22, 2023 | 92.93 | 1.00 | 1.09% | 91.93 | 92.93 | 91.93 |
| May 19, 2023 | 92.43 | -0.21 | -0.23% | 92.64 | 93.45 | 91.93 |
| May 18, 2023 | 92.93 | -0.75 | -0.80% | 93.68 | 93.78 | 91.95 |
| May 17, 2023 | 93.73 | 1.60 | 1.74% | 92.13 | 94.03 | 91.93 |
| May 16, 2023 | 92.42 | 0.26 | 0.28% | 92.16 | 92.95 | 92.16 |
| May 15, 2023 | 91.28 | 0.74 | 0.82% | 90.54 | 92.92 | 90.03 |
| May 12, 2023 | 90.18 | -1.26 | -1.38% | 91.44 | 92.40 | 90.03 |
| May 11, 2023 | 91.44 | -1.78 | -1.91% | 93.22 | 94.53 | 91.44 |
| May 10, 2023 | 93.99 | 0.96 | 1.03% | 93.03 | 95.03 | 91.84 |
| May 9, 2023 | 92.93 | 2.00 | 2.20% | 90.93 | 93.63 | 90.93 |
| May 8, 2023 | 92.11 | 1.17 | 1.29% | 90.94 | 92.11 | 90.93 |
| May 5, 2023 | 91.83 | 0.90 | 0.99% | 90.93 | 93.05 | 90.93 |
Utah Medical Products, Inc. Events
| Tijd (UTC) (UTC) | Land | Evenement |
|---|---|---|
| Thursday, June 15, 2023 | ||
| Tijd (UTC) (UTC) 12:00 | Land US
| Evenement Utah Medical Products Inc Utah Medical Products IncForecast -Previous - |
| Monday, July 24, 2023 | ||
| Tijd (UTC) (UTC) 10:59 | Land US
| Evenement Q2 2023 Utah Medical Products Inc Earnings Release Q2 2023 Utah Medical Products Inc Earnings ReleaseForecast -Previous - |
| Monday, October 23, 2023 | ||
| Tijd (UTC) (UTC) 13:00 | Land US
| Evenement Q3 2023 Utah Medical Products Inc Earnings Release Q3 2023 Utah Medical Products Inc Earnings ReleaseForecast -Previous - |
- Jaarlijks
- Per kwartaal
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Totale inkomsten | 52.281 | 49.054 | 42.178 | 46.904 | 41.998 |
| Inkomsten | 52.281 | 49.054 | 42.178 | 46.904 | 41.998 |
| Kosten van opbrengsten, totaal | 20.085 | 18.137 | 16.63 | 17.438 | 15.692 |
| Brutowinst | 32.196 | 30.917 | 25.548 | 29.466 | 26.306 |
| Totale bedrijfskosten | 32.491 | 30.174 | 28.47 | 29.272 | 23.301 |
| Verkoop/Algemeen/Admin. Uitgaven, Totaal | 4.857 | 4.879 | 11.354 | 11.351 | 7.155 |
| Onderzoek & Ontwikkeling | 0.493 | 0.526 | 0.486 | 0.483 | 0.454 |
| Bedrijfsresultaat | 19.79 | 18.88 | 13.708 | 17.632 | 18.697 |
| Renteopbrengsten (-uitgaven), netto Niet-operationeel | 0.661 | 0.166 | 0.112 | 0.254 | 0.249 |
| Overige, Netto | 0.208 | 0.015 | 0.02 | -0.002 | 0.513 |
| Netto inkomen voor belastingen | 20.659 | 19.061 | 13.84 | 17.884 | 19.459 |
| Netto inkomen na belastingen | 16.473 | 14.788 | 11.061 | 14.461 | 15.325 |
| Netto inkomen voor extra. Posten | 16.473 | 14.788 | 11.061 | 14.461 | 15.325 |
| Netto inkomen | 16.473 | 14.788 | 10.798 | 14.727 | 18.555 |
| Inkomsten beschikbaar voor gewone aandelen Excl. Extra. Posten | 16.473 | 14.788 | 11.061 | 14.461 | 15.325 |
| Inkomsten beschikbaar voor gewone aandelen Incl. Extra. Posten | 16.473 | 14.788 | 10.798 | 14.727 | 18.555 |
| Verwaterd Netto Inkomen | 16.473 | 14.788 | 10.798 | 14.727 | 18.555 |
| Verwaterd Gewogen Gemiddelde Aandelen | 3.643 | 3.66 | 3.672 | 3.739 | 3.748 |
| Verwaterde Winst per Aandeel Exclusief Buitengewone Posten | 4.52182 | 4.04044 | 3.01225 | 3.86761 | 4.08885 |
| Dividends per Share - Common Stock Primary Issue | 1.17 | 1.145 | 1.125 | 1.105 | 1.085 |
| Verwaterde Genormaliseerde Winst per Aandeel | 4.66847 | 4.0451 | 3.01225 | 3.86761 | 4.08885 |
| Totale buitengewone posten | -0.263 | 0.266 | 3.23 | ||
| Depreciation / Amortization | 6.386 | 6.61 | |||
| Ongebruikelijke uitgaven (inkomsten) | 0.67 | 0.022 |
| Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
|---|---|---|---|---|---|
| Totale inkomsten | 12.52 | 13.574 | 12.955 | 13.428 | 12.323 |
| Inkomsten | 12.52 | 13.574 | 12.955 | 13.428 | 12.323 |
| Kosten van opbrengsten, totaal | 4.677 | 5.247 | 4.769 | 5.277 | 4.79 |
| Brutowinst | 7.843 | 8.327 | 8.186 | 8.151 | 7.533 |
| Totale bedrijfskosten | 8.081 | 8.504 | 7.814 | 8.371 | 7.801 |
| Verkoop/Algemeen/Admin. Uitgaven, Totaal | 3.26 | 3.134 | 2.933 | 2.959 | 2.888 |
| Onderzoek & Ontwikkeling | 0.144 | 0.123 | 0.112 | 0.135 | 0.123 |
| Bedrijfsresultaat | 4.439 | 5.07 | 5.141 | 5.057 | 4.522 |
| Overige, Netto | 0.68 | -0.14 | 0.198 | 0.142 | 0.008 |
| Netto inkomen voor belastingen | 5.119 | 5.591 | 5.339 | 5.199 | 4.53 |
| Netto inkomen na belastingen | 4.214 | 4.555 | 4.28 | 4.103 | 3.534 |
| Netto inkomen voor extra. Posten | 4.214 | 4.555 | 4.28 | 4.103 | 3.534 |
| Netto inkomen | 4.214 | 4.555 | 4.28 | 4.103 | 3.534 |
| Inkomsten beschikbaar voor gewone aandelen Excl. Extra. Posten | 4.214 | 4.555 | 4.28 | 4.103 | 3.534 |
| Inkomsten beschikbaar voor gewone aandelen Incl. Extra. Posten | 4.214 | 4.555 | 4.28 | 4.103 | 3.534 |
| Verwaterd Netto Inkomen | 4.214 | 4.555 | 4.28 | 4.103 | 3.534 |
| Verwaterd Gewogen Gemiddelde Aandelen | 3.636 | 3.625 | 3.634 | 3.65 | 3.665 |
| Verwaterde Winst per Aandeel Exclusief Buitengewone Posten | 1.15897 | 1.25655 | 1.17777 | 1.12411 | 0.96426 |
| Dividends per Share - Common Stock Primary Issue | 0.295 | 0.295 | 0.295 | 0.29 | 0.29 |
| Verwaterde Genormaliseerde Winst per Aandeel | 1.15897 | 1.25655 | 1.17777 | 1.12411 | 0.96426 |
| Renteopbrengsten (-uitgaven), netto Niet-operationeel | 0.661 |
- Jaarlijks
- Per kwartaal
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Totaal vlottende activa | 89.919 | 73.158 | 62.262 | 54.886 | 60.903 |
| Geldmiddelen en kortetermijnbeleggingen | 75.052 | 60.974 | 51.59 | 42.787 | 51.112 |
| Cash | |||||
| Korte Termijn Investeringen | 0 | ||||
| Totale Vorderingen, Netto | 5.538 | 5.132 | 4.104 | 4.742 | 3.956 |
| Accounts Receivable - Trade, Net | 5.538 | 5.132 | 4.09 | 4.699 | 3.943 |
| Total Inventory | 8.814 | 6.596 | 6.222 | 6.913 | 5.412 |
| Prepaid Expenses | 0.515 | 0.456 | 0.346 | 0.444 | 0.423 |
| Total Assets | 123.874 | 115.636 | 111.745 | 109.787 | 99.768 |
| Property/Plant/Equipment, Total - Net | 10.224 | 11.067 | 11.326 | 10.728 | 10.359 |
| Property/Plant/Equipment, Total - Gross | 33.168 | 33.869 | 33.91 | 32.598 | 31.549 |
| Accumulated Depreciation, Total | -22.944 | -22.802 | -22.584 | -21.87 | -21.19 |
| Goodwill, Net | 13.354 | 14.098 | 14.164 | 13.961 | 13.703 |
| Intangibles, Net | 10.377 | 17.313 | 23.993 | 30.212 | 14.803 |
| Total Current Liabilities | 5.96 | 3.745 | 3.791 | 3.448 | 5.26 |
| Accounts Payable | 1.218 | 0.761 | 0.788 | 1.098 | 0.975 |
| Accrued Expenses | 4.405 | 2.948 | 3 | 2.35 | 3.44 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities, Total | 0.337 | 0.036 | 0.003 | 0.845 | |
| Total Liabilities | 9.62 | 8.498 | 8.923 | 8.694 | 10.776 |
| Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
| Deferred Income Tax | 2.063 | 2.682 | 2.802 | 2.76 | 3.075 |
| Total Equity | 114.254 | 107.138 | 102.822 | 101.093 | 88.992 |
| Preferred Stock - Non Redeemable, Net | 0 | 0 | |||
| Common Stock | 0.036 | 0.037 | 0.036 | 0.037 | 0.037 |
| Additional Paid-In Capital | 0.251 | 0.841 | 0.115 | 0.018 | 0.122 |
| Retained Earnings (Accumulated Deficit) | 126.006 | 115.314 | 110.952 | 110.82 | 100.123 |
| Other Equity, Total | -12.039 | -9.054 | -8.281 | -9.782 | -11.29 |
| Total Liabilities & Shareholders’ Equity | 123.874 | 115.636 | 111.745 | 109.787 | 99.768 |
| Total Common Shares Outstanding | 3.628 | 3.655 | 3.643 | 3.722 | 3.72 |
| Other Liabilities, Total | 1.597 | 2.071 | 2.33 | 2.486 | 2.441 |
| Geldmiddelen & Equivalenten | 75.052 | 60.974 | 51.59 | 42.787 | 51.112 |
| Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
|---|---|---|---|---|---|
| Totaal vlottende activa | 95.112 | 89.919 | 84.242 | 78.953 | 79.48 |
| Geldmiddelen en kortetermijnbeleggingen | 80.912 | 75.052 | 69.511 | 66.224 | 65.873 |
| Geldmiddelen & Equivalenten | 80.912 | 75.052 | 69.511 | 66.224 | 65.873 |
| Totale Vorderingen, Netto | 3.818 | 5.538 | 6.034 | 4.938 | 5.72 |
| Accounts Receivable - Trade, Net | 3.818 | 5.538 | 6.034 | 4.938 | 5.72 |
| Total Inventory | 9.94 | 8.814 | 8.31 | 7.338 | 7.367 |
| Other Current Assets, Total | 0.387 | 0.453 | |||
| Total Assets | 127.77 | 123.874 | 118.413 | 116.149 | 119.803 |
| Property/Plant/Equipment, Total - Net | 10.241 | 10.224 | 10.258 | 10.591 | 10.997 |
| Goodwill, Net | 13.502 | 13.354 | 12.871 | 13.396 | 13.903 |
| Intangibles, Net | 8.915 | 10.377 | 11.042 | 13.209 | 15.423 |
| Total Current Liabilities | 6.074 | 5.96 | 6.269 | 4.439 | 6.098 |
| Accounts Payable | 1.028 | 1.218 | 1.289 | 0.818 | 1.454 |
| Accrued Expenses | 5.046 | 4.742 | 4.98 | 3.621 | 4.644 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 9.752 | 9.62 | 10.227 | 8.678 | 10.635 |
| Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
| Deferred Income Tax | 2.094 | 2.063 | 1.929 | 2.196 | 2.209 |
| Other Liabilities, Total | 1.584 | 1.597 | 2.029 | 2.043 | 2.328 |
| Total Equity | 118.018 | 114.254 | 108.186 | 107.471 | 109.168 |
| Common Stock | 0.036 | 0.036 | 0.036 | 0.036 | 0.037 |
| Additional Paid-In Capital | 0.322 | 0.251 | 0.058 | 0 | 0.903 |
| Retained Earnings (Accumulated Deficit) | 129.15 | 126.006 | 122.522 | 119.293 | 117.788 |
| Other Equity, Total | -11.49 | -12.039 | -14.43 | -11.858 | -9.56 |
| Total Liabilities & Shareholders’ Equity | 127.77 | 123.874 | 118.413 | 116.149 | 119.803 |
| Total Common Shares Outstanding | 3.628 | 3.628 | 3.625 | 3.625 | 3.655 |
| Prepaid Expenses | 0.442 | 0.515 | 0.52 |
- Jaarlijks
- Per kwartaal
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Netto-inkomen/Beginsaldo | 16.473 | 14.788 | 10.798 | 14.727 | 18.555 |
| Geldmiddelen uit Operationele Activiteiten | 21.147 | 21.203 | 20.137 | 17.056 | 16.834 |
| Geldmiddelen uit Operationele Activiteiten | 0.612 | 0.636 | 0.655 | 0.7 | 0.765 |
| Amortization | 6.417 | 6.645 | 6.515 | 6.144 | 2.191 |
| Deferred Taxes | -0.401 | -0.092 | -0.026 | -0.396 | -0.326 |
| Niet-Geldelijke Posten | 0.272 | 0.232 | 0.202 | 0.204 | -0.309 |
| Cash Taxes Paid | 4.97 | 4.617 | 3.186 | 5.304 | 4.851 |
| Contant Betaalde Rente | 0 | 0 | 0 | 0 | |
| Veranderingen in het Operationeel Kapitaal | -2.226 | -1.006 | 1.993 | -4.323 | -4.042 |
| Geldmiddelen uit Investeringsactiviteiten | -0.818 | -0.552 | -0.86 | -21.54 | 0.534 |
| Kapitaaluitgaven | -0.818 | -0.552 | -0.86 | -21.54 | -0.402 |
| Geldmiddelen uit Financieringsactiviteiten | -5.484 | -10.905 | -10.734 | -4.227 | -4.777 |
| Financiering van Cash Flow Posten | 0 | ||||
| Total Cash Dividends Paid | -3.163 | -11.465 | -4.116 | -4.112 | -4.026 |
| Uitgifte (Aflossing) van aandelen, netto | -2.321 | 0.56 | -6.618 | -0.115 | -0.751 |
| Wisselkoerseffecten | -0.767 | -0.362 | 0.26 | 0.386 | -1.354 |
| Nettowijziging in Geldmiddelen | 14.078 | 9.384 | 8.803 | -8.325 | 11.237 |
| Uitgifte (Aflossing) van Schulden, Netto | |||||
| Overige Cash Flow investeringsposten, Totaal | 0 | 0.936 |
| Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
|---|---|---|---|---|---|
| Net income/Starting Line | 4.214 | 16.473 | 11.918 | 7.638 | 3.534 |
| Cash From Operating Activities | 6.915 | 21.147 | 15.467 | 9.878 | 5.046 |
| Cash From Operating Activities | 0.155 | 0.612 | 0.454 | 0.302 | 0.149 |
| Amortization | 1.596 | 6.417 | 4.837 | 3.257 | 1.646 |
| Deferred Taxes | -0.003 | -0.401 | -0.409 | -0.286 | -0.144 |
| Non-Cash Items | 0.066 | 0.272 | 0.181 | 0.135 | 0.065 |
| Cash Taxes Paid | 0.129 | 4.97 | 3.502 | 2.467 | 0.082 |
| Cash Interest Paid | 0 | ||||
| Changes in Working Capital | 0.887 | -2.226 | -1.514 | -1.168 | -0.204 |
| Cash From Investing Activities | -0.043 | -0.818 | -0.78 | -0.459 | -0.237 |
| Capital Expenditures | -0.043 | -0.818 | -0.78 | -0.459 | -0.237 |
| Cash From Financing Activities | -1.049 | -5.484 | -4.564 | -3.532 | 0.019 |
| Total Cash Dividends Paid | -1.07 | -3.163 | -2.112 | -1.06 | 0 |
| Issuance (Retirement) of Stock, Net | 0.021 | -2.321 | -2.452 | -2.472 | 0.019 |
| Foreign Exchange Effects | 0.037 | -0.767 | -1.586 | -0.637 | 0.071 |
| Net Change in Cash | 5.86 | 14.078 | 8.537 | 5.25 | 4.899 |
| Naam investeerder | Type investeerder | Percentage uitstaand | Aandelen in bezit | Wijziging aandelen | Datum bezit | Omzetcijfer |
|---|---|---|---|---|---|---|
| Fidelity Management & Research Company LLC | Investment Advisor | 10.524 | 381817 | 25 | 2023-03-31 | LOW |
| T. Rowe Price Investment Management, Inc. | Investment Advisor | 9.6426 | 349840 | 7924 | 2023-03-31 | MED |
| Renaissance Technologies LLC | Hedge Fund | 5.6976 | 206714 | -3900 | 2023-03-31 | HIGH |
| Cornwell (Kevin L) | Individual Investor | 5.1948 | 188472 | 0 | 2023-03-03 | LOW |
| BlackRock Institutional Trust Company, N.A. | Investment Advisor | 4.9577 | 179868 | -6138 | 2023-03-31 | LOW |
| The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 4.6563 | 168935 | 1245 | 2023-03-31 | LOW |
| Dimensional Fund Advisors, L.P. | Investment Advisor/Hedge Fund | 4.2595 | 154538 | 1170 | 2023-03-31 | LOW |
| Rice Hall James & Associates, LLC | Investment Advisor/Hedge Fund | 3.1456 | 114123 | -243 | 2023-03-31 | LOW |
| Healthinvest Partners AB | Investment Advisor/Hedge Fund | 2.5909 | 94000 | 8000 | 2022-12-31 | MED |
| JP Morgan Asset Management | Investment Advisor | 2.3018 | 83512 | 4167 | 2023-03-31 | LOW |
| Ranger Investment Management, L.P. | Investment Advisor | 1.999 | 72525 | -2562 | 2023-03-31 | MED |
| State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 1.9693 | 71446 | 1421 | 2023-03-31 | LOW |
| Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.9683 | 71411 | 1085 | 2023-03-31 | LOW |
| Russell Investments Trust Company | Investment Advisor | 1.9153 | 69488 | 3838 | 2023-03-31 | LOW |
| Loomis, Sayles & Company, L.P. | Investment Advisor/Hedge Fund | 1.42 | 51520 | -884 | 2023-03-31 | LOW |
| Franklin Mutual Advisers, LLC | Investment Advisor/Hedge Fund | 1.1493 | 41696 | 0 | 2023-03-31 | MED |
| Goldman Sachs Asset Management, L.P. | Investment Advisor | 1.1263 | 40863 | -132 | 2023-03-31 | LOW |
| Royce Investment Partners | Investment Advisor/Hedge Fund | 0.9002 | 32659 | 2696 | 2023-03-31 | LOW |
| Northern Trust Investments, Inc. | Investment Advisor/Hedge Fund | 0.8532 | 30955 | 281 | 2023-03-31 | LOW |
| Clean Yield Asset Management | Investment Advisor | 0.7079 | 25683 | 9614 | 2023-03-31 | LOW |
Waarom Capital.com? De cijfers spreken voor zichzelf.
Capital.com Group535K+
Handelaren
87K+
Actieve klanten per maand
$113M+
Maandelijks beleggingsvolume
$64M+
Opgenomen per maand
Handelscalculator
Bereken uw virtuele winst- en verliesrekening indien u een CFD-positie had geopend op een bepaalde datum (kies een datum) en gesloten op een andere datum (kies een datum).
Handelscommissie
0
- 1:1
Hefboom
1:1
- 20
- 100
- 500
- 1000
- 10000
Investering
Positiegrootte (hefboomwerking x investering):
Openingskoers
Slotkoers
Short Long
Utah Medical Products, Inc. Company profile
Over Utah Medical Products, Inc.
Utah Medical Products, Inc. (UTMD) vervaardigt en verkoopt een reeks gespecialiseerde medische hulpmiddelen. De productcategorieën omvatten arbeid en bevalling/verloskunde, waaronder foetale bewakingsaccessoires, vacuümondersteunde toedieningssystemen (VAD) en andere hulpmiddelen voor arbeid en bevalling; neonatale intensive care, waaronder DISPOSA-HOOD, DELTRAN PLUS en GESCO; gynaecologie/urologie/elektrochirurgie, met inbegrip van LETZ System, FINESSE+ Generator, EPITOME en OptiMicro elektrochirurgische instrumenten, Filshie Clip System, PATHFINDER PLUS, SUPRAPUBISCHE CATHETERIZATIE, LIBERTY System, ENDOCURETTE, TVUS/HSG-Cath en LUMIN en bloeddrukbewaking, met inbegrip van DELTRAN Disposable Pressure Transducer (DPT), en accessoires, componenten en andere gegoten onderdelen voor bloeddrukbewaking. De medische hulpmiddelen worden rechtstreeks verkocht aan klinische eindgebruikersfaciliteiten of aan een aangewezen voorraadhoudende distributeur voor een medische faciliteit. Daarnaast worden sommige van zijn hulpmiddelen verkocht via distributeurs en nationale ziekenhuisdistributiebedrijven.
| Industry: | Medical Equipment, Supplies & Distribution (NEC) |
7043 S 300 West
MIDVALE
UTAH 84047
US
Winst- en verliesrekening
- Annual
- Quarterly
Mensen bekijken ook
Nog steeds op zoek naar een broker die u kunt vertrouwen?
Sluit u aan bij de 535.000+ handelaren die er wereldwijd voor kozen om met Capital.com te handelen